Has Robert Frenck received payments from drug or device companies?

Yes. Drug and device makers reported $76,564 in general payments to Robert Frenck across 47 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Frenck did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Frenck come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Frenck

Pediatric Infectious Diseases · Cincinnati, OHNPI 1558378943

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Pfizer at 44.1% of the total. Reporting peaked in 2023 at $41,741 and has fallen 87.2% since, to $5,357 in 2024. Among pediatric infectious diseases clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,564in general payments, 2019–2025

Across 47 payments — averaging $1629.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$34K
Sanofi Pasteur Inc.$23K
Janssen Scientific Affairs, LLC$7K
Merck$7K
Biontech SE$5K
Seqirus USA Inc$2K

$13,203,946in research payments, 2019–2025

Across 224 payments — averaging $58,946 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$11M
GSK$1.5M
Emergent Biosolutions Inc.$624K
Bavarian Nordic A/s$131K
Janssen Research & Development, LLC$5K
Merck$153

What the payments were for

Consulting fees$39,94252%
Speaking & faculty fees$22,88130%
Travel & lodging$13,04717%
Food & beverage$6601%
Education$150%
Gifts$200%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	15	$33,792
Sanofi Pasteur Inc.	22	$22,541
Janssen Scientific Affairs, LLC	4	$6,625
Merck	3	$6,540
Biontech SE	1	$4,900
Seqirus USA Inc	2	$2,166

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COMIRNATY$29,432
FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)$1,158

How this compares

$76,564 in reported general payments places this provider in the 95th percentile of 43 pediatric infectious diseases providers in Ohio.

See all pediatric infectious diseases providers in Ohio →

Other pediatric infectious diseases in Cincinnati

David BernsteinCincinnati$67K
Lara Danziger-IsakovCincinnati$27K
Sing Sing WayCincinnati$16K
Mary StaatCincinnati$9K
Elizabeth SchlaudeckerCincinnati$7K
Grant PaulsenCincinnati$891
Mark MurphyCincinnati$322
David HaslamCincinnati$127
Samir ShahCincinnati$101
Sanjay JainCincinnati$51

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →